VAERS reports by lot

Merck Pneumococcal lot T039322: VAERS reports

37 VAERS reports list lot T039322 as a Merck Pneumococcal vaccine, received between 2021-07-05 and 2023-02-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
5%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3927%
General / Systemic (non-local)3524%
Injection-site / Local reaction2115%
Gastrointestinal1611%
Musculoskeletal86%
Dermatological (non-injection-site)86%
Neurological53%
Respiratory53%
Allergic / Anaphylactic43%
Thrombotic / Hematological32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas10
New York6
California2
Georgia2
Alaska2
Indiana1
Iowa1
Maine1
Florida1
Missouri1
South Dakota1
Ohio1

Reports by month received

2021-075
2021-087
2021-094
2021-103
2021-114
2021-121
2022-013
2022-042
2022-051
2022-072
2022-093
2022-111
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.